Haystack Oncology Launches With $56 Million In Series A Financing To Accelerate Adoption Of Post-Op Cancer Detection Technology And Optimize Cancer Therapy Monitoring And Treatment
Amount Raised
$56 Million
Round Type
Series A
BaltimoreBiotechnologyHealth CareMedicalInvestors
Description
Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to optimize minimal residual disease (MRD) testing and better inform decisions around therapy, today announced that it raised $56 million in Series A financing. The funding will be used for the continued development and planned 2023 commercialization of its best-in-class personalized cancer diagnostic test that can detect as few as one mutant molecule in a million DNA molecules, positioning it as the most sensitive ctDNA-based MRD test for use in solid tumors. The financing was led by Catalio Capital Management ("Catalio"), which co-founded Haystack through its private equity and structured equity investment vehicles. Additional investors include Bruker, Exact Ventures, the venture arm of Exact Sciences and Alexandria Venture Investments.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Haystack Oncology that raised within 45 days of this round, from Fundz verified event records.
- LIPOGEMS raised $13M (Funding Round) on December 23, 2022.
- PVmed raised $14M (Series A) on December 23, 2022.
- Streamex Corp. raised $1.1M (Seed) on December 21, 2022.
- Fountain Life raised $15M on December 15, 2022.
- KeyOps raised $4M (Seed) on December 13, 2022.
- Ubie raised an undisclosed amount (Series C) on December 8, 2022.
Who to call at Haystack Oncology, and when
A new round usually means Haystack Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Haystack Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haystack Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haystack Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haystack Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansHaystack Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.